Avenue Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.78; its P/E ratio is -0.08; Avenue Therapeutics is scheduled to report earnings on May 13, 2024, and the estimated EPS forecast is $-9.00. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	-	-	-	-	$ 3.21M
Gross Profit	-	-	-	-	$ 3.21M
EBIT	$ 949.00K	$ 513.00K	$ -4.02M	$ -1.11M	$ 5.08M
EBITDA	$ 949.00K	$ 513.00K	$ -4.02M	$ -1.11M	$ 6.19M
Net Income Common Stockholders	$ 640.00K	$ 526.00K	$ -4.01M	$ -1.04M	$ 3.99M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 1.78M	$ 161.00K	$ 1.57M	$ 8.24M	$ 6.71M
Total Assets	$ 1.85M	$ 502.00K	$ 1.67M	$ 8.45M	$ 6.84M
Total Debt	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Net Debt	$ -1.78M	$ -161.00K	$ -1.57M	$ -8.24M	$ -6.71M
Total Liabilities	$ 1.20M	$ 5.02M	$ 7.81M	$ 10.60M	$ 3.58M
Stockholders Equity	$ 1.58M	$ -3.65M	$ -5.34M	$ -1.45M	$ 3.90M
Cash Flow	-
Free Cash Flow	$ -2.32M	$ -919.00K	$ -4.67M	$ -1.57M	$ -4.17M
Operating Cash Flow	$ -2.32M	$ -919.00K	$ -4.67M	$ -1.57M	$ -4.17M
Investing Cash Flow	-	$ -1.00M	$ -2.00M	-	-
Financing Cash Flow	$ 3.95M	$ 479.00K	-	$ 3.10M	$ 10.66M

Currency in USD

Avenue Therapeutics Earnings and Revenue History

Income Statement >

Avenue Therapeutics Debt to Assets

Balance Sheet >

Avenue Therapeutics Cash Flow

Cash Flow >

Avenue Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing